{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:59:42Z","timestamp":1761919182596},"reference-count":57,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T00:00:00Z","timestamp":1228780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Idiopathic inflammatory demyelinating disorders (IIDD) affect the central nervous system. In classical multiple sclerosis (CMS), brain, optic nerves [optic neuritis (ON)] and spinal cord [acute transverse myelitis (ATM)] are affected. In neuromyelitis optica (NMO), optic nerves and spinal cord are predominantly affected. NMO\u2010IgG, an autoantibody targeting aquaporin\u20104, is a marker for NMO. We studied the frequency and clinical relevance of NMO\u2010IgG seropositivity in IIDD patients.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Neuromyelitis optica\u2010IgG was detected by indirect immunofluorescence using primate cerebellum.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Neuromyelitis optica\u2010IgG was detected in six of 10 NMO patients (60%), six of 10 idiopathic relapsing transverse myelitis (IRTM) patients (60%), two of nine idiopathic relapsing ON patients (22%), one of 11 patients (9%) having single ON attack, one of 30 CMS patients (3%), and none of patients having single ATM attack or controls. Comparing NMO\u2010IgG seropositive (<jats:italic>n<\/jats:italic>\u2003=\u200312) with NMO\u2010IgG seronegative (<jats:italic>n<\/jats:italic>\u2003=\u20038) patients having NMO or IRTM, NMO\u2010IgG seropositivity was associated with a higher relapse rate in first 2\u2003years, 1.5 and 0.6 attacks\/year for seropositive and seronegative groups respectively (<jats:italic>P<\/jats:italic>\u2003=\u20030.006), and non\u2010significant trend towards more severe ON and myelitis with poorer clinical outcome.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Neuromyelitis optica \u2010IgG facilitates diagnosis of NMO spectrum disorders. NMO\u2010IgG seropositivity is associated with higher relapse rate in first 2\u2003years.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2008.02376.x","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T00:11:34Z","timestamp":1228867894000},"page":"310-316","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Neuromyelitis optica\u2010IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese"],"prefix":"10.1111","volume":"16","author":[{"given":"K. H.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. B.","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H. H.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C. Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. W. L.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S. C.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H. W.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,5]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009283431307"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08220-X"},{"key":"e_1_2_6_4_2","first-page":"1033","article-title":"Myelite subaigue compliquee de nevrite optique","volume":"8","author":"Devic ME","year":"1895","journal-title":"Bulletin Medical (Paris)"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70216-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf260"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00308-9"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70333-7"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.5.1107"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(02)00043-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-36534"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms947oa"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0271-0"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000254502.87233.9a"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/112.1.133"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.62.4.601"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(02)00040-9"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17551-X"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050304"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.080390"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1984.04050210105027"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410340211"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf151"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3280be58d8"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.209.269"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl371"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0169-2"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-007-0828-7"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.4.1219"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100053932"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.7.957"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei263"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000159399.81861.D5"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20770"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000303817.82134.da"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20703"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.4.499"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000216139.44259.74"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.05.001"},{"key":"e_1_2_6_41_2","first-page":"S157","article-title":"NMO\u2010IgG and opticospinal multiple sclerosis and idiopathic recurrent myelitis","volume":"12","author":"Kim KK","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"e_1_2_6_42_2","first-page":"S155","article-title":"Neuromyelitis optica autoantibody (NMO\u2010IgG) in patients with suspected NMO or limited forms of NMO","volume":"12","author":"Zuliani L","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"e_1_2_6_43_2","first-page":"S3","article-title":"An audit of the diagnostic usefulness of the NMO\u2010IgG assay for neuromyelitis optica","volume":"12","author":"Littleton ET","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"e_1_2_6_44_2","first-page":"S4","article-title":"NMO\u2010IgG: a French experience","volume":"12","author":"Marignier GT","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"e_1_2_6_45_2","first-page":"S157","article-title":"Probable NMO IgG in Turkish patients with Devic\u2019s disease, and multiple sclerosis","volume":"12","author":"Akman\u2010Demir G","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000256822.01222.bd"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01376.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.10.1398"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm027"},{"key":"e_1_2_6_50_2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1242\/jcs.114.7.1297","article-title":"Role of aquaporin\u20104 water channel in the development and integrity of the blood\u2010brain barrier","volume":"114","author":"Nico B","year":"2001","journal-title":"Journal of Cell Science"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1252"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2004.07.055"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000289761.64862.ce"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm062"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.17"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.6.851"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01392.x"},{"issue":"1","key":"e_1_2_6_58_2","first-page":"A236","article-title":"Coexisting autoimmune channelopathies: neuromyelitis optica (NMO) with myasthenia gravis (MG)","volume":"70","author":"Chan KH","year":"2008","journal-title":"Neurology"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2008.02376.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2008.02376.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:36:45Z","timestamp":1697355405000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2008.02376.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,5]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1468-1331.2008.02376.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02376.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,5]]},"assertion":[{"value":"2009-02-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}